News
Serum Institute’s partner NeuClone develops mAb for breast cancer indication
NeuClone's Perjeta (pertuzumab) biosimilar is partnered with Serum Institute of India (Serum). Under the partnership, NeuClone and Serum are developing ten biosimilars for global markets.
DBT calls for proposals to establish Biotech-KISAN Hubs
This special Call for Proposals is for establishing Biotech-KISAN Hubs in four agro-climatic zones in the country.
Prime Minister Narendra Modi inaugurates the Partners Forum - 2018
Prime Minister Narendra Modi inaugurated the Partners’ Forum, 2018, in New Delhi on December 12th. He also released the coffee table book ‘Proven Paths’, a compendium of 36 best practices in maternal, child and adolescent health, at the inaugural ceremony.
